drugset / Trial / NCT02172430

Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172430

Phase 3 Completed 161 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to investigate the long-term safety of Ba 79 BR (tiotropium) powder inhalation in patients with COPD using oxitropium bromide (Tersigan) as a comparator. Secondarily, the long-term efficacy of Ba 679 BR is also investigated

Timeline

Start
2000-09
Primary completion
2002-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxitropium Small molecule 100 ug Inhaled
Subject Tiotropium Other / unclassified 18 ug Inhaled